1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
North America Automated Compounding Systems Market to 2027- Covid-19 Impact and Regional Analysis by Product Type ; End User, and Country - Regional Analysis and Market Forecasts by Drug Class and Action Mechanism

North America Automated Compounding Systems Market to 2027- Covid-19 Impact and Regional Analysis by Product Type ; End User, and Country - Regional Analysis and Market Forecasts by Drug Class and Action Mechanism

  • July 2020
  • 92 pages
  • ID: 5934823
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Jun 20th 2021


Table of Contents

Search Inside

The North America automated compounding systems market is expected to reach US$ 339.69 million by 2027 from US$ 197.53 million in 2019. The market is estimated to grow with a CAGR of 7.2% from 2020 to 2027.
The automated compounding systems marketis growing primarily due to the growing adoption of chemotherapy, personalized medication, and rising need to minimize medication errors in the North America region.High cost of the automated compounding systems and COVID-19 pandemic are likely to restrain the growth of the market in coming years.

Additionally, increasing awareness about automated compounding systems among pharmacists and introduction of novel robotic technology automation in compounding systemsare likely to increase the growth of the automated compounding systems market during the forecast period.
Automated compounding system is a device that combines one or more drug solutions to final container for patient administration.Automated compounding system helps avoid medication error that occurs due to variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion caused due to the use of similar labels.

However, with the automated compounding systems, the accuracy as well as efficiency of dispensing compounded products have improved, and it has further reduced the exposure of healthcare professionals to toxic agents.
The rapid adoption of novel therapies, such as chemotherapy in oncology has been reported to provide better treatment options for breast, lung, and prostate cancers.The area of precision and personalized medicine (PPM) is developed to make therapies for a single patient or specific groups based on data that captures current and past physical health and environmental experience.

Recently, several reports showed that the assimilation of PPM viewpoint into cancer research and treatment will result into significant enhancements in fighting cancer, mainly due to its complexity and interpatient unpredictability. Diana (ICU Medical, Inc.) helps to reduce human data entry errors and increase preparation traceability. Diana uses ChemoClave components to protect clinicians against dangerous drugs and unintended needle sticks while treating the patients. Therefore, the increasing adoption of chemotherapy is ranked among the leading factors for the growth of the automated compounding systems market.
Organizations and associations are working toward creating awareness among pharmacists about medication processes.For instance, as per the American Association of Colleges of Pharmacy (AACP), 2019, the Pharmacists for Healthier Lives campaign is a national effort in order to grow awareness regarding pharmacists’ roles in delivering quality health care.

The campaign is maintained by a coalition of pharmacy organizations that comprises AACP, the American Society of Health-System Pharmacists, the Academy of Managed Care Pharmacy and the Accreditation Council for Pharmacy Education, the National Alliance of State Pharmacy Associations, the Georgia Pharmacy Association, and Prescribe Wellness. These associations have been working toward spreading awareness among the population, which in turn is fuelling the growth of automated compounding systems market.
Research institutes, pharmaceutical, and biotech companies are engaged in collaborative work to address the COVID-19 outbreak.This has eventually shifted their focus from their regular supply of automated compounding systems.

Majority of the companies which are operating in the manufacturing segment of automated compounding systems products are currently working on Personal Protective Equipment (PPE), such as gloves, masks, and gowns.In the upcoming years, the research activities are expected to accelerate owing to their potential in treating wide range of diseases.

The COVID-19 outbreak highlights potential vulnerabilities in both our drug supply chain and clinical infrastructure, including the availability of adequate clinician resources.
In 2019, the gravimetric automated compounding systems segment accounted for the largest share in the North America automated compounding systems market. The growth of the gravimetric automated compounding systems is attributed to accuracy provided by the systems, preference by the pharmacies and hospitals for the gravimetric systems, enormous commercial use of these systems in the market.
Some of the significant secondary sources for automated compounding systems market included in the report are the Food and Drug Administration (FDA), National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP), American Association of Colleges of Pharmacy (AACP), and others

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Ovarian Cancer Treatment Drugs Markets in China

  • $ 4000
  • May 2021
  • 272 pages

China’s demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a ...

  • China
  • Ovarian Cancer
  • Chemotherapy
  • Industry analysis
  • Industrial Production
  • Labour Force


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on